← BZYR Overview

Burzynski Research Institute Inc Liquidation Value Calculator

Burzynski Research Institute Inc

Current Price: N/A

Loading calculator data...

Advanced: All 48 XBRL Tags

Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.

Balance Sheet

TagValueUnit
accounts_payable
Accounts Payable Current total
AccountsPayableCurrent
$45,101 USD
cash
Cash And Cash Equivalents At Carrying Value total
CashAndCashEquivalentsAtCarryingValue
$2,165 USD
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
$2,165 USD
current_liabilities
Accrued Liabilities Current total
AccruedLiabilitiesCurrent
$24,507 USD
liabilities_total
Liabilities total $69,608 USD
shares_outstanding
Common Stock Shares Outstanding total
CommonStockSharesOutstanding
131.4M shares
Unmapped Tags (40)
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
$130.27MUSD
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
$244,783USD
Assets
Assets
$2,265USD
Assets Current
AssetsCurrent
$2,265USD
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
$0USD/shares
Common Stock Shares Authorized
CommonStockSharesAuthorized
$200.00Mshares
Common Stock Shares Issued
CommonStockSharesIssued
$131.45Mshares
Common Stock Value
CommonStockValue
$131,449USD
Deferred Tax Assets Gross
DeferredTaxAssetsGross
$173,097USD
Deferred Tax Assets Net
DeferredTaxAssetsNet
$0USD
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
$130,494USD
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
$42,603USD
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
$173,097USD
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
$2,265USD
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
$-130.47MUSD
Stockholders Equity
StockholdersEquity
$-67,343USD
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
$1,318USD
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
$28,084USD
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
$-960USD
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
$100USD
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
$968,474USD
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
$-967,156USD
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
$600,000shares
Earnings Per Share Basic
EarningsPerShareBasic
$-0USD/shares
Earnings Per Share Diluted
EarningsPerShareDiluted
$-0USD/shares
General And Administrative Expense
GeneralAndAdministrativeExpense
$207,991USD
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
$-994,180USD
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
$0USD
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
$-5,398USD
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
$-208,778USD
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
$5,398USD
Net Income Loss
NetIncomeLoss
$-994,180USD
Operating Expenses
OperatingExpenses
$994,180USD
Operating Income Loss
OperatingIncomeLoss
$-994,180USD
Prepaid Expense Current
PrepaidExpenseCurrent
$100USD
Research And Development Expense
ResearchAndDevelopmentExpense
$786,189USD
Revenues
Revenues
$0USD
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
$24,507USD
Profit Loss
ProfitLoss
$-994,180USD
ProceedsFromContributedCapital
ProceedsFromContributedCapital
$230,441USD

Showing balance sheet tags only. Liquidation analysis uses balance sheet data.

Comments